Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Lee's Pharmaceutical Limited clinical trials
The registry lists 92 studies whose lead sponsor is Lee's Pharmaceutical Limited or one of 2 companies grouped under it. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Lee's Pharmaceutical Limited studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lee's Pharmaceutical Limited.
- Lee's Pharmaceutical Limited74 studiesSame company
Something wrong?
- Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.17 studies →Divested — left Lee's Pharmaceutical Limited, Oct 2020 · source ↗
Something wrong?
- Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited1 study →Divested — left Lee's Pharmaceutical Limited, Oct 2020 · source ↗
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 →
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy VolunteersNot yet recruitingNCT07887490Phase 1
- Evaluation of PAN-90806 Eye Drops in Healthy SubjectsNot yet recruitingNCT07764965Phase 1
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant TumorsRecruitingNCT06953453Phase 1
- Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard TreatmentRecruitingNCT06374485Phase 1
- Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary HypertensionRecruitingNCT07099144
- A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseRecruitingNCT06766357Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical CancerRecruitingNCT06459687Phase 3
- Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)RecruitingNCT06160492Phase 3
- Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia PatientsRecruitingNCT06948357Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye PatientsNot yet recruitingNCT06942793Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation RecipientsRecruitingNCT06114953Phase 4
- A Study of Atropine Sulfate in Healthy Chinese VolunteersRecruitingNCT05855018Phase 1
Sponsor listed in the registry: Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited · First submitted after Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited left Lee's Pharmaceutical Limited
- Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Otic Solution in the Treatment of Acute Otitis ExternaCompletedNCT04636957Phase 3
- Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial DefectCompletedNCT07132437Phase 1
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Istaroxime Infusion for 24 Hours in Chinese Healthy VolunteersCompletedNCT02477449Phase 1
- To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic KeratitisCompletedNCT07120308Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye DropsActive, not recruitingNCT06209320Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye DropsActive, not recruitingNCT06209281Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye DropsCompletedNCT06209203Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal AtrophyCompletedNCT04982692Phase 3
- Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcPCompletedNCT05531422Phase 2
- A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLCCompletedNCT04878016Phase 3
- A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsCompletedNCT06212973Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical TrialCompletedNCT06213727Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted after Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT02617459Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted before Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient ManufacturerStatus unknownNCT05806918Phase 3
- Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung CancerStatus unknownNCT04346914Phase 1
- A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.Status unknownNCT04460066Phase 1/2
- Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseCompletedNCT04541888Phase 3
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted before Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in PopulationStatus unknownNCT05249725Phase 4
- Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic MelanomaStatus unknownNCT04849260Phase 1/2
- An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant RecipientsStatus unknownNCT05293704Phase 4
- Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution(FERPLEX) in Women With Gynecologic Iron Deficiency AnemiaStatus unknownNCT05192291
- A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial CarcinomaStatus unknownNCT04603846Phase 1
- A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract CancerStatus unknownNCT04608786Phase 1
- Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial DefectsStatus unknownNCT04228926Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted before Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical StudyCompletedNCT03967548Phase 1
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted before Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- A Study of the Continuous Glucose Monitoring System for Home Use in Patients With DiabetesStatus unknownNCT04964752Not applicable
- Anfibatide Phase Ib-IIa Clinical TrialCompletedNCT01585259Phase 1/2
- A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical CancerStatus unknownNCT03676959Phase 1
- A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal CancerStatus unknownNCT04846842Phase 2
- Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer PainStatus unknownNCT04713189Phase 1/2
- An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese VolunteersStatus unknownNCT04627116Phase 1
- A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT04571489Phase 2
- A Study of Gimatecan (ST1481) in Small Cell Lung CancerStatus unknownNCT04501029Phase 2
- Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy VolunteersSuspendedNCT04404790Phase 1
- Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry EyeCompletedNCT03676335Phase 2
Sponsor listed in the registry: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · First submitted before Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. left Lee's Pharmaceutical Limited
- Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant ChemotherapyStatus unknownNCT04359550Phase 3
- A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne VulgarisCompletedNCT03615768Phase 3
- Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma PatientsStatus unknownNCT03904628Phase 1